This article was originally published in The Tan Sheet
U.S. Codex office requesting comments on "Proposed Draft Working Principles for Risk Analysis" by Oct. 1. Redrafted document appears to take a step away from recognition of so-called "precautionary principle," or the application of precaution absent scientific data, within Codex itself, although it does not address the issue with regard to risk analysis guidance for governments. Document restates Codex Commission's position that when evidence of human health risk exists but scientific data are insufficient, the commission "should not proceed to elaborate a standard but should consider elaborating a related text, such as a code of practice...supported by the available scientific evidence." Redrafted document will be considered by Codex Committee on General Principles at its meeting in Paris April 15-19, 2002
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC